Browsing Tag

Partnering

580 posts

Moderna, Baxter in Mfg Pact for COVID Vaccine; Supply Updates in Asia
By

By
Moderna and Baxter BioPharma Solutions have entered into an agreement for Baxter to provide fill–finish sterile manufacturing and supply packaging for approximately 60 million to 90 million doses of the…

Pharma COVID Roundup: News from Lilly, AstraZeneca, GSK, Pfizer, Roche
By

By
The latest on manufacturing, potential treatments, and testing for COVID-19 with news from Lilly, AstraZeneca, GSK, Pfizer, Roche, Merck & Co., Thermo Fisher, and others. Manufacturing and supply of COVID-19…

Global Pharma Briefs: News from Roche, Lilly, and Dr. Reddy’s
By

By
A roundup of news from the US (Dr. Reddy’s Laboratories, Roche, Lilly, and Biolojic). US Dr. Reddy’s Issues Recall of Generic LipitorDr. Reddy’s Laboratories has initiated a voluntary recall of…

Merck & Co. To Manufacture J&J’s COVID-19 Vaccine
By

By
Merck & Co. has entered into an agreement with Janssen Pharmaceuticals, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (J&J), to support the manufacturing and supply of J&J’s…

Global Pharma Briefs: News from AstraZeneca, Pfizer, Merck & Co., Gilead
By

By
A roundup of news from China (AstraZeneca, Junshi Biosciences), the UK (Pfizer, GSK, CPI), and the US (Gilead Sciences, Merck & Co., AstraZeneca, AbbVie, Mitokinin). China AstraZeneca, Junshi Biosciences in…

Takeda To Divest Diabetes Drugs for $1.2 Bn; In $856-M Rare-Disease Pact
By

By
As part of ongoing divestment program of non-core assets following its $62-billion acquisition of Shire in 2019, Takeda Pharmaceutical has agreed to sell select non-core diabetes products in Japan to…

Novartis, BeiGene Close $2.2-Bn Licensing Deal for Oncology Drug
By

By
Novartis has closed on its $2.2-billion licensing agreement and collaboration with BeiGene, a Beijing-based pharmaceutical company, for tislelizumab, an oncology drug. Earlier this year (January 2021), the companies agreed to…

Merck KGaA, Debiopharm in $1.1-Bn Licensing Pact for Cancer Therapy
By

By
Merck KGaA has entered into a global in-licensing agreement with Debiopharm, a Lausanne, Switzerland-based biopharmaceutical company, for the development and commercialization of xevinapant, a treatment for locally advanced squamous cell…

Pfizer, Moderna, J&J Plan COVID-19 Vaccine Supply Increase; Evaluating Variants
By

By
Pfizer/BioNTech, Moderna, and Johnson & Johnson (J&J) have detail plans to increase supply of their respective COVID-19 vaccines to the US. The companies have also provided updates on variant studies.…

Pharma COVID Roundup: News from Sanofi, GSK, Novavax, Regeneron
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from the Biden Administration, Sanofi, GlaxoSmithKline, Novavax, and Regeneron. Manufacturing and supply of COVID-19 vaccines and drugs President Joe…